MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, H.-J.
Right arrow Articles by Surh, Y.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, H.-J.
Right arrow Articles by Surh, Y.-J.

Vol. 60, Issue 3, 440-449, September 2001

Differential Cell Death Induced by Salsolinol with and without Copper: Possible Role of Reactive Oxygen Species

Hyun-Jung Kim, Yunjo Soh, Jung-Hee Jang, Jeong-Sang Lee, Young J. Oh, and Young-Joon Surh

College of Pharmacy, Seoul National University, Seoul, Korea (H.-J.K., J.-H.J., J.-S.L., Y.-J.S.); Department of Neuroscience, Graduate School of East-West Medical Science, Kyung Hee University, Youngin-city, Kyungki-do, Korea (Y.S.); and Department of Biology, Yonsei University, Seoul, Korea (Y.J.O.)

Salsolinol (SAL), a novel dopaminergic catechol tetrahydroisoquinoline neurotoxin, has been speculated to contribute to the etiology of Parkinson's disease and neuropathology of chronic alcoholism. Our previous studies have demonstrated that SAL induces strand scission in øX174 supercoiled DNA and oxidative base modification in calf thymus DNA in the presence of cupric ion. We now report that treatment of rat pheochromocytoma (PC12) cells with SAL causes reduced viability, which was exacerbated by Cu2+. The copper chelator bathocuproinedisulfonic acid ameliorated cytotoxicity induced by SAL and Cu2+. N-Acetyl-L-cysteine and reduced glutathione protected against SAL- plus Cu2+-mediated PC12 cell death. Cells exposed to SAL underwent apoptosis, as revealed by characteristic morphological and biochemical changes. SAL treatment resulted in increased levels of Bax with a concomitant decrease in expression of Bcl-xL. Furthermore, SAL rapidly activated c-Jun N-terminal kinase, whereas the activity of extracellular signal-regulated protein kinase remained unchanged. Transfection with Bcl-xL or Bcl-2 led to protection against SAL-mediated PC12 cell death. Although SAL alone could cause apoptotic death in PC12 cells, cells treated with SAL together with Cu2+ became necrotic. Cells exposed to both SAL and Cu2+ exhibited higher levels of intracellular reactive oxygen species, malondialdehyde, and 8-oxo-7,8-dihydro-2'-deoxyguanosine than did those treated with SAL alone. These results suggest that copper accelerates redox cycling of SAL, leading to massive production of reactive oxygen species, which can divert the SAL-induced cell death to necrosis.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J.-H. Jang and Y.-J. Surh
Bcl-2 Attenuation of Oxidative Cell Death Is Associated with Up-regulation of {gamma}-Glutamylcysteine Ligase via Constitutive NF-{kappa}B Activation
J. Biol. Chem., September 10, 2004; 279(37): 38779 - 38786.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Mao, F. Qin, C. Iwai, R. Vulapalli, P. C. Keng, and C.-s. Liang
Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H29 - H39.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics